bc

The Final Asset

book_age18+
0
FOLLOW
1K
READ
dark
arrogant
badboy
drama
no-couple
kicking
genius
campus
city
office/work place
high-tech world
another world
lawyer
like
intro-logo
Blurb

Jack Vane was a brilliant forensic accountant until he broke the rules to save his sister. Now he's disgraced, broke, and desperate. Emily is dying of Cellular Degradation Syndrome—a disease engineered by the World Investment Corporation (WIC) to test their immortality project. The only cure costs $5 million.

WIC makes Jack an offer he can't refuse: Enter "The Labyrinth," a deadly survival game run by the corporation. Survive the games, and WIC will cure Emily. But Jack quickly discovers the game is rigged. To survive, he must hack the System from the inside, exploiting the very loopholes that built WIC's empire. As he uncovers the truth about Project Lazarus, Jack realizes he isn't just playing for the prize—he's playing to expose the company that uncovers the truth about Project Lazarus, Jack realizes he isn't just playing for the prize—he's playing to expose the company that poisoned his sister.

chap-preview
Free preview
Chapter 1: The Ledger of the Damned
--- **Chapter 1: The Ledger of the Damned** The contract was a lie. Jack Vane found it in the second paragraph, buried under a clause about "performance-based compensation." The numbers didn't reconcile. A mid-level logistics firm with a $2.3 million annual revenue shouldn't be paying its CFO a $4 million bonus. Not unless the CFO was being paid for something other than logistics. He circled the discrepancy with a red pen, the way he'd done a thousand times before. His apartment was dark except for the desk lamp, the rain drumming against the window a steady rhythm. On the screen in front of him, the shell company's financials spread like a patient on an operating table. Found you. Jack had spent twelve years as a forensic accountant, and he'd learned one thing above all else: people lie, but numbers don't. Numbers leave trails. Numbers tell you where the body is buried. He'd built his career on that principle. He'd exposed embezzlement rings, uncovered offshore tax havens, dismantled a billion-dollar Ponzi scheme with nothing but a calculator and an unhealthy obsession with discrepancies. He'd been good at it. The best in his firm. Until the firm realized his "unorthodox data acquisition" methods were a liability. They'd revoked his license six months ago. He hadn't stopped working. His phone buzzed. A text from the hospital. *Emily's latest bloodwork attached. Doctor wants to discuss treatment options. Call when you can.* Jack stared at the message. He didn't open the attachment. He didn't need to. He already knew what it said. Cellular Degradation Syndrome. Rare. Aggressive. Terminal. Six months, maybe less. He set the phone face-down on the desk and forced himself back to the contract. Their mother had died twelve years ago. Their father had left long before that. It had been the two of them ever since—Jack and Emily, against a world that kept finding new ways to take from them. Two years ago, when Emily was diagnosed, Jack had done what any brother would do. He'd panicked. He'd researched. He'd called every specialist, every clinic, every experimental trial in the country. And then WIC had appeared like a miracle. World Investment Corporation. Experimental treatment program. No cost to the patient. It had been a lifeline. Jack had been suspicious, of course—he was suspicious of everything—but Emily was dying, and suspicion wasn't a cure. He'd signed the paperwork. He'd watched her get admitted. He'd believed. Now, two years later, she was still dying. And the "no cost" treatment had somehow accrued $5 million in administrative fees. Jack didn't have $5 million. He had $4,000 and a mountain of debt. And a growing suspicion that the math didn't add up. He pulled up WIC's financial records. He'd been hacking their lower-level servers for six months now, looking for anything that would explain the fees. It was like peeling an onion made of titanium. Every layer revealed three more layers of encryption. But Jack wasn't a hacker; he was a forensic accountant. He didn't need to break the door down when he knew exactly where they hid the spare key. The first layer was always the easiest. He found a vulnerability in their payroll software—a software his own firm had audited three years ago. The flaw was simple: the system trusted internal IP addresses without secondary authentication. Jack spoofed an internal address, and the firewall let him through like a VIP at a nightclub. Six months to live, he thought, cross-referencing WIC's pharmaceutical division records against Emily's patient file. And they just happened to have a cure. Numbers like that don't exist in nature. Somebody engineered the shortfall. He scrolled through the pharmaceutical records. Line after line of experimental compounds, gene therapies, and clinical trials. Most were redacted. A few had batch codes and dates. He catalogued them all in a separate spreadsheet, building a map of WIC's research division. That was when he saw it. A compound called CDS-402. Classified as a "cellular degradation agent." The description was clinical, almost sterile: *Induces accelerated cellular decay in human subjects. Used for controlled studies of degenerative conditions.* Jack frowned. He cross-referenced the batch code against Emily's file. Nothing. Her file didn't list CDS-402. It listed a different treatment protocol entirely. He kept digging. The system's search function was slow, deliberately throttled to prevent mass data extraction. He had to navigate it manually, one query at a time. It took him twenty minutes to find what he was looking for. A hidden log. Not in the patient files, but in the research division's internal records. A list of test subjects who had received CDS-402. Emily's name was on it. Jack's blood ran cold. He checked the date. The injection came three weeks after her diagnosis. They hadn't treated her. They had infected her. A sharp ping cut through the rain. A new file populated on his secondary monitor. PROJECT LAZARUS: PLAYER REGISTRY. Jack frowned. Lazarus. He'd seen that word before—buried in WIC's internal ledgers, line item 44B. Labyrinth Operations. He'd never been able to figure out what it meant. He'd assumed it was a codename for a new product line. Something benign. He opened the file. Hundreds of names. Ages. Occupations. And next to each name, a date of termination. Jack's eyes froze on line 104. *Name: Emily Vane. Status: Active. Estimated Value: Tier 1 Asset.* Asset. The word didn't fit. Patients weren't assets. Patients were charts and diagnoses and treatment plans. Assets were inventory. Assets were things you owned. He scrolled down. There was a transaction record attached to Emily's file. He opened it. *Patient: VANE, EMILY. Treatment Protocol: SYNTHETIC RETROVIRAL INJECTION. Batch: CDS-402. Injection Date: [redacted].* Jack sat perfectly still. The rain hammered against the window. The clock on his monitor blinked 3:14 AM. And the numbers on the screen rearranged themselves into a truth he couldn't unsee. They hadn't treated her. They had infected her. And now they were holding the cure hostage for $5 million. A warning flashed at the bottom of his screen. UNAUTHORIZED ACCESS DETECTED. TERMINAL LOCKOUT IN 30 SECONDS. Jack didn't move. He just stared at the batch code, the date, the word *Asset* burned into his retinas. Thirty seconds. ---

editor-pick
Dreame-Editor's pick

bc

Yüzbaşının Cerrahı

read
1.6M
bc

The Silver Wolf

read
631.2K
bc

The Billionaire’s Intern

read
1.2M
bc

Chosen, just to be Rejected

read
913.0K
bc

Inferno Demon Riders MC: My Five Obsessed Bullies

read
1.2M
bc

Claimed by the Biker Giant

read
2.3M
bc

Unscentable

read
2.3M

Scan code to download app

download_iosApp Store
google icon
Google Play
Facebook